Anzeige
Mehr »
Freitag, 06.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PQTV | ISIN: SE0011178458 | Ticker-Symbol: KN0
Frankfurt
06.06.25 | 08:01
0,045 Euro
-8,16 % -0,004
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
DICOT PHARMA AB Chart 1 Jahr
5-Tage-Chart
DICOT PHARMA AB 5-Tage-Chart

Aktuelle News zur DICOT PHARMA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
28.05.DICOT PHARMA AB: Dicot Pharma's new findings on mechanism of action: "affects the nerves controlling penile erection"2
DICOT PHARMA Aktie jetzt für 0€ handeln
06.05.DICOT PHARMA AB: Report from the Annual General Meeting of Dicot Pharma1
29.04.Dicot Pharma AB: Dicot Pharma presents interim report Q1 2025121Uppsala, Sweden, April 29, 2025. Dicot Pharma AB publishes its interim report for the first quarter of 2025. The report is available as an attached document and on www.dicotpharma.com. The company's...
► Artikel lesen
17.04.DICOT PHARMA AB: Dicot Pharma publishes its annual report for 20242
03.04.DICOT PHARMA AB: Summon to Annual General Meeting in Dicot Pharma May 6 at 17.001
02.04.DICOT PHARMA AB: Dicot Pharma's TO 6 subscribed at 96% and provides the company SEK 43.8 million2
26.03.DICOT PHARMA AB: Last day of trading in Dicot Pharma TO 6 warrants tomorrow, March 271
17.03.DICOT PHARMA AB: Dicot Pharma invites to a Q&A session on TO 61
17.03.DICOT PHARMA AB: Exercise Period for Warrants TO6 in Dicot Pharma Begins Today1
13.03.DICOT PHARMA AB: Letters of Intent from Major Shareholders, Board, and Management to Subscribe for SEK 11 million in Dicot Pharma's TO 6, Running Until March 31, 20251
11.03.DICOT PHARMA AB: Subscription Price SEK 0.38 for Warrants TO 6 in Dicot Pharma Determined; corresponding to SEK 0.19 per share1
26.02.DICOT PHARMA AB: Professor after ESSM Holding AB: "The interest in Dicot Pharma's work continues to grow"4
13.02.Dicot Pharma AB: Dicot Pharma AB Year-End Report 202482Uppsala, Sweden, February 13, 2024. Dicot Pharma publishes its year-end report for the financial year 2024 and for the fourth quarter. The report is available as an attached document and on www.dicotpharma.com....
► Artikel lesen
05.02.DICOT PHARMA AB: Half of the participants now dosed in Dicot Pharma's Phase 2a study2
19.12.24DICOT PHARMA AB: Entire Patent Family Reaching Approval in the United States2
17.12.24DICOT PHARMA AB: French Expert to Present Results from Dicot Pharma at ESSM Holding AB2
20.11.24Dicot Pharma AB: First participants dosed in Dicot Pharma's Phase 2a clinical study155Uppsala, Sweden, November 20, 2024. The first participants in Dicot Pharma's Phase 2a clinical study have now been dosed. The company's drug candidate LIB-01 is being developed as a new first-line treatment...
► Artikel lesen
06.11.24Nasdaq Stockholm AB: Listing of Dicot Pharma AB on Nasdaq First North Growth Market Sweden294On request of Dicot Pharma AB, company registration number 559006-3490, Nasdaq Stockholm AB has admitted the company's shares and equity rights to trading on Nasdaq First North Growth Market Sweden...
► Artikel lesen
13.08.24XFRA CAPITAL ADJUSTMENT INFORMATION - 13.08.2024522Das Instrument EEMU IE00BMDBMX02 INVESCOM2 EMU ESG UNI SCR ETF wird cum Kapitalmassnahme gehandelt am 13.08.2024 und ex Kapitalmassnahme am 14.08.2024 The instrument EEMU IE00BMDBMX02 INVESCOM2 EMU...
► Artikel lesen
19 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1